PT - JOURNAL ARTICLE AU - Woodcock, Ramsi A. AU - Bartels, Loren J. TI - Preliminary Evidence of a Link between COVID-19 Vaccines and Otologic Symptoms AID - 10.1101/2022.02.23.22271144 DP - 2022 Jan 01 TA - medRxiv PG - 2022.02.23.22271144 4099 - http://medrxiv.org/content/early/2022/02/24/2022.02.23.22271144.short 4100 - http://medrxiv.org/content/early/2022/02/24/2022.02.23.22271144.full AB - Hypothesis This study investigates whether U.S. Centers for Disease Control and Prevention Vaccine Adverse Events Reporting System (VAERS) data suggest an association between vertigo, tinnitus, hearing loss, Bell’s palsy and the COVID-19 vaccines administered in the United States.Background Published case reports suggest a possible association between various otologic symptoms and the COVID-19 vaccines, but the only published analysis of VAERS data, which did not account for underreporting of late-appearing adverse events, found no association between hearing loss and the vaccines.Methods The incidence in VAERS of vertigo, tinnitus, hearing loss, and Bell’s palsy associated with COVID-19 vaccinations administered between December 14, 2020 and June 7, 2021 was compared with published rates for the general population. To account for underreporting of late-appearing adverse events, incidences were calculated using only the initial part of the observation period, during which reported events spike above expected events.Results The COVID-19 vaccines were associated with statistically significant increases in the incidence of vertigo, tinnitus, hearing loss, and Bell’s palsy of 1877, 50, 12, and 14 cases per 100,000, respectively. In relation to the mRNA-1273 or BNT162b2 vaccines, the Ad26.COV2.S vaccine was associated with a statistically significant excess incidence of vertigo, tinnitus, and hearing loss of at least 723, 57, and 55 cases per 100,000, respectively.Conclusion These results suggest an association between the COVID-19 vaccines and vertigo, tinnitus, hearing loss, and Bell’s palsy. They also suggest that, with respect to vertigo, tinnitus, and hearing loss, the association is relatively strong for the Ad26.COV2.S vaccine.Competing Interest StatementRamsi A. Woodcock suffers from otologic symptoms that he believes to have been caused by COVID-19 vaccination. He is Loren J. Bartels' patient.Funding StatementThis study did not receive any funding.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study uses data from the Vaccine Adverse Event Reporting System (VAERS) that is publicly available on the CDC website at https://wonder.cdc.gov/vaers.html.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesNo data were produced for the study. All data analyzed in this study were downloaded from https://wonder.cdc.gov/vaers.html. All data and calculations used in the study can be downloaded in Excel format from this link: https://www.dropbox.com/s/82m4h7cba9g6h4v/TinnitusHearingLossVAERS%205.xlsx?dl=0